Clinical Trial Manager Clinical Research & Development HaematologyOctapharma Pharmazeutika Produktionsges.m.b.HVienna, Wien, Austria
PB0235 - Phase 3 Study of the Efficacy, Pharmacokinetics, Immunogenicity and Safety of von Willebrand Factor/Factor VIII Concentrate in Patients with Severe von Willebrand Disease under 6 Years of Age
Sunday, June 25, 202318:30 – 19:30 ET
